Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Karlsson

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
BMC Cancer|January 4, 2013
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcomeEmman Shubbar, Anikó Kovács, Shahin Hajizadeh, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trialAxel Stenmark Tullberg, Martin Sjöström, Lena Tran, et al.
BMC Cancer|February 28, 2025
The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT: a randomized clinical trial with long-term follow-upMoa Egelberg, Tommaso De Marchi, Niklas Schultz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2012
Long-term symptoms after radiotherapy of supraclavicular lymph nodes in breast cancer patientsDan Lundstedt, Magnus Gustafsson, Gunnar Steineck, et al.
Frontiers in Oncology|February 23, 2023
Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinomaElisabeth Werner Rönnerman, Daniella Pettersson, Szilárd Nemes, et al.
Orvosi Hetilap|January 21, 2003
[Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study]Adám Vas, Judit Sóvágó, Christer Halldin, et al.
Case Reports in Oncology|December 28, 2017
Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic AnalysisJenny Nyqvist, Fredrik Persson, Toshima Z Parris, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 7, 2022
Estimating the Risk for Secondary Cancer After Targeted α-Therapy with <sup>211</sup>At Intraperitoneal RadioimmunotherapyErik Leidermark, Andreas Hallqvist, Lars Jacobsson, et al.
Neurobiology of Aging|December 8, 2009
Dopamine D(1) receptors and age differences in brain activation during working memoryLars Bäckman, Sari Karlsson, Håkan Fischer, et al.
International Journal of Cancer|October 12, 2013
Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinomaToshima Z Parris, Anikó Kovács, Luaay Aziz, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
BMC Cancer|January 4, 2013
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcomeEmman Shubbar, Anikó Kovács, Shahin Hajizadeh, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trialAxel Stenmark Tullberg, Martin Sjöström, Lena Tran, et al.
BMC Cancer|February 28, 2025
The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT: a randomized clinical trial with long-term follow-upMoa Egelberg, Tommaso De Marchi, Niklas Schultz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2012
Long-term symptoms after radiotherapy of supraclavicular lymph nodes in breast cancer patientsDan Lundstedt, Magnus Gustafsson, Gunnar Steineck, et al.
Frontiers in Oncology|February 23, 2023
Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinomaElisabeth Werner Rönnerman, Daniella Pettersson, Szilárd Nemes, et al.
Orvosi Hetilap|January 21, 2003
[Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study]Adám Vas, Judit Sóvágó, Christer Halldin, et al.
Case Reports in Oncology|December 28, 2017
Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic AnalysisJenny Nyqvist, Fredrik Persson, Toshima Z Parris, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 7, 2022
Estimating the Risk for Secondary Cancer After Targeted α-Therapy with <sup>211</sup>At Intraperitoneal RadioimmunotherapyErik Leidermark, Andreas Hallqvist, Lars Jacobsson, et al.
Neurobiology of Aging|December 8, 2009
Dopamine D(1) receptors and age differences in brain activation during working memoryLars Bäckman, Sari Karlsson, Håkan Fischer, et al.
International Journal of Cancer|October 12, 2013
Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinomaToshima Z Parris, Anikó Kovács, Luaay Aziz, et al.
Pageof 18